Pediatric Oncologists are medical specialists dedicated to diagnosing and treating cancer in children, from infancy through adolescence. Because cancers in children often differ biologically from those in adults, pediatric oncologists undergo extensive training in both general pediatrics and oncology. They manage a range of childhood cancers, including leukemia, lymphoma, brain tumors, and rare solid tumors, using treatments like chemotherapy, immunotherapy, targeted drugs, and bone marrow transplants. Their focus extends beyond simply treating the disease—they also consider how treatment impacts a child’s growth, development, and long-term health, often working to prevent or reduce potential late effects.
These specialists also provide comprehensive support for families navigating a cancer diagnosis. Pediatric oncologists lead a multidisciplinary team that includes pediatric nurses, social workers, psychologists, and child life specialists, ensuring that both medical and emotional needs are addressed. They communicate in age-appropriate ways with young patients while offering clear, compassionate guidance to caregivers. Because treatment often lasts months or even years, pediatric oncologists build deep, trusting relationships with families, supporting them through each phase of care. Their unique combination of medical expertise, emotional intelligence, and long-term care planning makes pediatric oncologists essential to helping young patients fight cancer and lead healthier lives beyond it.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China